Federal Funds to Support Infrastructure at New Penn State PGx Center | GenomeWeb

NEW YORK (GenomeWeb News) – The Penn State Hershey Cancer Institute at Penn State Milton S. Hershey Medical Center will open its new Center for Pharmacogenetics later this year, using $3.2 million in federal funds recently appropriated for the facility, the institute's director said Friday.

"The money will pay for infrastructure support in terms of data managers and research nurses that will help us accrue patients to the studies," as well as "perhaps maybe some statistical help," Tom Loughran, director of the cancer institute, told GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.